Researchers create process to inhibit proteins important in HIV and cancer

Using small molecules containing platinum, Virginia Commonwealth University Massey Cancer Center researchers have created a process to inhibit a class of proteins important in HIV and cancer.

The findings may help researchers develop new drugs to fight HIV or cancer by selectively targeting proteins known as zinc fingers.

In the journal Chemistry & Biology, researchers reported that a zinc finger protein, known as HIV NCp7, can be inhibited when it is exposed to a platinum complex. They observed that when the HIV NCp7 protein interacts with platinum, the zinc portion of the molecule is ejected from the protein chain. This causes the protein to lose its tertiary structure or overall shape. For these molecules, shape is an important property that enables the protein to carry out certain biological functions.

The process, active site displacement, involved design of a platinum drug with higher affinity for the protein peptide backbone, thus eliminating the zinc from its active site.

In the specific case discussed in the paper, the HIV NCp7 protein is responsible for the proliferation of the HIV virus. If researchers can inhibit the action of this zinc finger protein, they can stop the spread of the virus.

“When we target specific viruses with drugs, over time patients can become resistant to treatment and the drug becomes ineffective. Therefore, novel biological processes and proteins are attractive targets for antiviral drug development,” said lead author Nicholas Farrell, Ph.D., professor and chair in the Department of Chemistry at VCU and a member scientist with the VCU Massey Cancer Center.

According to Farrell, these study findings may also one day be applied to the selective targeting of zinc fingers involved in the biological processes responsible for the spread of cancer. By applying the concept to development of anticancer drugs, the researchers hope to design more specific clinical agents with reduced side effects compared to the very useful, but toxic, cisplatin and congeners.

http://www.vcu.edu

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

Sex and violence may not really sell products   GPs and the Fit for Work scheme   Study shows global warming is unlikely to reduce winter deaths   Academies make recommendations for improving public health   As death rates drop, nonfatal diseases and injuries take a bigger toll on health globally   Designing better medical implants   Single low-magnitude electric pulse successfully fights inflammation   Total annual hospital costs could be reduced by rapid candidemia identification   UTMB develops new online tool for nurses   Online health information - keep it simple!   Your privacy online: Health information at serious risk of abuse   Physician guidelines for Googling patients need revisions